victoza glp 1 FDA Approves Hikma's Generic Version of GLP-1 Diabetes Drug FDA approves first generic liraglutide
Description
GLP-1 AND THE WORKPLACE STUDY: Researchers in Indianapolis are launching a first of its kind study about the impact of GLP-1s on the workplace
As fatty liver disease continues to drive downstream costs, this signal is getting serious attention
From skin and hair concerns to shifts in spend and routines, this is a structural change, not a passing trend!!
Reduced appetite and food noise
By 2030, the global prevalence of obesity is expected to reach one billion
Other adverse effects, including depression, sleep disturbances, and anxiety, have also been noted.While these side effects are usually transient, they can be bothersome enough to prompt some patients to discontinue treatment prematurely
